Bayer Aktiengesellschaft (BAYRY)
| Market Cap | 21.91B |
| Revenue (ttm) | 52.13B |
| Net Income (ttm) | -981.49M |
| Shares Out | n/a |
| EPS (ttm) | -1.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.02 (0.40%) |
| Ex-Dividend Date | Apr 29, 2024 |
| Volume | 1,620,500 |
| Average Volume | 2,059,541 |
| Open | 5.55 |
| Previous Close | 5.43 |
| Day's Range | 5.54 - 5.65 |
| 52-Week Range | 4.79 - 9.06 |
| Beta | 1.00 |
| RSI | 67.17 |
| Earnings Date | Mar 5, 2025 |
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare produc... [Read more]
News
Bayer AG Enterprise Digital Transformation Strategy Report 2024: Accelerators, Incubators, and Innovation Programs
Dublin, Jan. 20, 2025 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Bayer AG 2024" report has been added to ResearchAndMarkets.com's offering.
Leaps by Bayer Announces One of the Largest Global Surveys of Society's Attitudes Toward Breakthrough Technologies
BERLIN--(BUSINESS WIRE)--As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the...
New U.S. Survey Conducted On Behalf Of One A Day® by Bayer Highlights Four in Five GenZ Women Feel Societal Pressures Impact Their New Year's Resolutions
WHIPPANY, N.J.--(BUSINESS WIRE)--A new survey commissioned by One A Day®, the multivitamin and supplement brand by Bayer rooted in more than 80 years of nutritional science, suggests that societal pre...
YourUpdateTV Speaks with Kelly Bristow from Bayer About Simple Tips for a Healthier 2025
Registered Dietitian & Nutritionist from Bayer, Kelly Bristow, Shares Expert Tips to Help You Kickstart Your Health and Wellness Journey Registered Dietitian & Nutritionist from Bayer, Kelly Bristow, ...
Jury says Bayer must pay $100M in trial over PCBs in Washington school
Bayer must pay $100 million in latest trial over PCBs in Washington school, jury finds
A Washington state jury on Tuesday said Bayer must pay $100 million to four people who say they were sickened by exposure to toxic chemicals known as PCBs made by the company's predecessor Monsanto th...
Bayer's Pharma Growth Strategy Progressing Well as Pipeline Advances
WHIPPANY, N.J.--(BUSINESS WIRE)--On the occasion of the 43rd J.P. Morgan Healthcare Conference in San Francisco, Bayer AG announces further progress in its pharmaceutical growth strategy with multiple...
Copper Ammonium Carbonate Market Outlook 2025-2030, with Competitive Analysis of Bayer, Hindalco, Hindustan Copper, Bhagyanagar India, ABC Gas, Gujarat Mineral Development and Baroda Extrusion
Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "Copper Ammonium Carbonate Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering. The copper ammonium carbonate...
Bayer pharma chief sees no big acquisitions in near future
Bayer will focus on paying down debt and not make any major acquisitions in the next two or three years, the head of the German company's pharmaceuticals division said in an interview published on Tue...
Bayer's investigational MRI contrast agent gadoquatrane meets primary and main secondary endpoints in pivotal Phase III studies
BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an in...
Bayer Submits Supplemental New Drug Application to U.S. FDA Seeking New Indication for KERENDIA® (finerenone) in Patients with Heart Failure with Left Ventricular Ejection Fraction of ≥40%
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced the submission of a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) for KERENDIA® (finerenone) for the tr...
Bayer hot flashes therapy for breast cancer patients hits main goal in late-stage trial
Bayer (BAYZF) (BAYRY) says elinzanetant, its experimental therapy for hot flashes, reached the main goals in a late-stage trial. Read more here.
Elinzanetant Meets All Primary and Secondary Endpoints in Phase III Study OASIS 4 for Treatment of Moderate to Severe Vasomotor Symptoms Caused by Breast Cancer Treatments
In OASIS 4, a Phase III study conducted outside of the US, the investigational compound elinzanetant met all primary endpoints demonstrating a statistically significant reduction in frequency of moder...
Bayer Menopause Drug Reduces Hot Flashes in Breast Cancer Group
Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the use case for the menopause treatment expected to launch as early as this ye...
Orion's collaboration partner Bayer submits application in China for third indication of darolutamide
ORION CORPORATION INVESTOR NEWS 7 JANUARY 2025 at 9:00 EET Orion's collaboration partner Bayer submits application in China for third indication of darolutamide Orion's collaboration partner ...
Bayer wins last pending Roundup case in Australia
Bayer Secures End of Roundup Weedkiller Litigation in Australia
The German pharmaceutical and agricultural conglomerate said the Federal Court of Australia closed the last pending case in the country over whether its Roundup weedkiller causes cancer.
Bayer Secures End of Roundup Weedkiller Litigation in Australia
The German pharmaceutical and agricultural conglomerate said the Federal Court of Australia closed the last pending case in the country over whether its Roundup weedkiller causes cancer.
Bayer: Federal Court Brings an End to Roundup™ Litigation in Australia
LEVERKUSEN, Germany--(BUSINESS WIRE)--The Federal Court of Australia brought an end to the last Roundup™ case in Australia, closing all pending injury litigation there. The Court granted the plaintiff...
Bayer: Sell And Be Done With It
A year after Bayer got rid of bosses and asked staff to self-organize, its CEO says attrition has fallen
Bayer told workers to self-organize last year as part of a plan to save €2 billion in costs by 2026.
Bayer's CEO said budgets represent the worst of corporate bureaucracy. He decided to turn the process on its head.
Bayer CEO Bill Anderson says "everyone hates" the budget process and the bureaucracy involved. So he implemented 90-day budget cycles.
Bayer Eye Drug Shows Positive Results in Late-Stage Trial
Bayer said its eye treatment aflibercept showed positive results in a late-stage trial, including improved vision gains for people suffering from some retinal diseases.
Bayer Eye Drug Shows Positive Results in Late-Stage Trial
Bayer said its eye treatment aflibercept showed positive results in a late-stage trial, including improved vision gains for people suffering from some retinal diseases.
Bayer Partners with America's Grow-A-Row to Aid in the Fight Against Hunger in New Jersey
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced the successful completion of its fall employee engagement campaign with America's Grow-a-Row (AGAR), a New Jersey-based, nonprofit farm where approxima...